Immuno-Oncology
non-CME
HUB
Simon Turcotte, MD, MSc (he/him/his)
Associate Professor of Hepatopancreatobiliary Surgery and Scientist
Université de Montréal
Disclosure information not submitted.
Multiple technologies are now available and being used to measure circulating tumor DNA in our patients. The purpose of this session is to understand how these work, the most recent data on their use for advanced colon cancer and pancreatic cancers, what the results mean, and how they can provide guidance on surgical decisions and timing of surgery.
HUB Presenter: Timothy E. Newhook, MD – The University of Texas MD Anderson Cancer Center
Presenter: Darren R. Carpizo, MD, PhD – University of Rochester